logo
Plus   Neg
Share
Email

AstraZeneca Plans To Raise Up To $3.5 Bln To Fund Daiichi Sankyo Deal

British drug major AstraZeneca Plc (AZN.L,AZN) announced Friday its intention to raise up to approximately $3.5 billion through a placing of new ordinary shares in the Company with both existing and new institutional investors.

The company plans to use the net proceeds of the proposed Placing to fund upfront and near-term payments in respect of the Company's global development and commercialisation collaboration agreement with Daiichi Sankyo Co. (DSKYF.PK) for trastuzumab deruxtecan (DS-8201) .

The proceeds will also be used for the repayment of the Company's $1 billion, 1.95% notes due on September 18, 2019; and for general corporate purposes, to improve the Company's overall balance-sheet strength and liquidity.

The net impact of the deal and the Placing is expected to be neutral to AstraZeneca's Core Earnings Per Share in 2019, growing Core EPS accretion from 2020 to a significant contribution in 2023.

Further, AstraZeneca reconfirmed its 2019 Product Sales and Core EPS guidance at constant exchange rates post-placing and transaction and confirms there is no change to the Company's progressive dividend policy.

The Transaction will become effective on March 29, 2019. The Placing is not conditional on completion of the Transaction.

AstraZeneca said the collaboration with Daiichi Sankyo is expected to reinforce its science-led strategy in Oncology that is based on four key scientific platforms. It is also consistent with the Company's financial objectives and investment priorities.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Justin Sun, the entrepreneur who founded the cryptocurrency platform TRON, has postponed his charity lunch with billionaire investor Warren Buffett due to ill health. "TRON Foundation announces postponement of Warren Buffett lunch, press conferences after founder Justin Sun falls ill with kidney stones.... Mountain Rose Herbs has recalled one lot of Fennel Seed Whole after the company found salmonella in part of its inventory. The Eugene, Oregon-based company has recalled all sizes ranging from 4 oz. to 50 lbs. of its Fennel Seed Whole, Lot #25031, because they have the potential to be contaminated... The U.S. Food and Drug Administration announced the suspension of the food facility registration of seafood producer Topway Enterprises Inc., also doing business as Kazy's Gourmet, following repeated food safety violations. From now, Topway will not be able to sell or distribute any food products.
Follow RTT